[Treatment of diabetes mellitus with a new sulfonamide with hypoglycemic effect:  N-(4-methyl-benzenesulfonyl) N-butyl urea].
D003920:Diabetes Mellitus / Q000628:therapy*; D007004:Hypoglycemic Agents; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D014508:Urea / Q000031:analogs & derivatives
D007004:Hypoglycemic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D014508:Urea
DIABETES MELLITUS/therapy; SULFONAMIDES/therapeutic use; UREA/related compounds
Contributo casistico alla terapia del diabete mellito con un nuovo derivato dei sulfamidici ad azione ipoglicemizzante:  la N-(4-metil-benzensulfonil)-N' -butil-urea.